Quote | bluebird bio Inc. (NASDAQ:BLUE)
|Last Trade Date Time:||12/08/2023 03:00:00 am|
News | bluebird bio Inc. (NASDAQ:BLUE)
The recent 4-year partnership between Pfizer and Beam Therapeutics involves $300 million upfront to speed validation of the technology and an additional $1.05 billion in milestone payments. A recent amended agreement between Verve Therapeutics and Beam Therapeutics is a target swap th...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...
Message Board Posts | bluebird bio Inc. (NASDAQ:BLUE)
|I have a similar position - 98,050 in||Moose412||investorshub||04/27/2023 7:08:18 AM|
|FYI||stocksrising||investorshub||04/24/2023 11:53:50 AM|
|Here is an example from a few accounts||stocksrising||investorshub||04/20/2023 11:46:16 AM|
|You picked up 90k shares since September?||Moose412||investorshub||04/20/2023 8:33:02 AM|
|I have ~100,000 reasons why Im hoping||stocksrising||investorshub||04/18/2023 9:52:26 PM|
News, Short Squeeze, Breakout and More Instantly...
bluebird bio Inc. Company Name:
BLUE Stock Symbol:
bluebird bio Inc. Website:
The FDA has approved Casgevy and Lyfgenia, representing the first cell-based gene therapies for sickle cell disease in patients 12 years ...
Bluebird Bio, Inc. (NASDAQ: BLUE) shares are trading higher Friday after Morgan Stanley upgraded Bluebird Bio from Underweight to Equal-Weight and ...
U.S. stocks traded mostly higher, with the Dow Jones index gaining more than 40 points on Friday. Shares of Torrid Holdings Inc. (NYSE: CURV) share...